CAPR
CAPR
US14070B3096
Capricor Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- 22.270.465
--
Cost of Revenue -- --
--
Gross Profit -- --
--
108.142.130 64.833.707
66.8%
Operating Income -108.142.130 -42.563.242
154.1%
Pretax Income -105.042.346 -40.465.586
159.6%
Net Income Common Stockholders -105.043.946 -40.467.186
159.6%
-- --
--
-- --
--
ende